FDA Adverse Event Injury Summary report: N

AVAULTA BIOSYNTHETIC SUPPORT SYSTEM: POSTERIOR

MDR report key: 2890669 · Received December 26, 2012

Report

Report Number
1018233-2012-02169
Event Type
Injury
Date Received
December 26, 2012
Report Date
December 22, 2015
Manufacturer
C.R. BARD, INC. (COVINGTON)
Product Code
FTL
PMA / PMN Number
K082571
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
ATTORNEY
Health Professional
N

Narratives

Additional Manufacturer Narrative · 1

THE SAMPLE WAS NOT RETURNED. THE LOT NUMBER IS UNKNOWN; THEREFORE, THE DEVICE HISTORY RECORD COULD NOT BE REVIEWED. THE INSTRUCTIONS FOR USE WHICH ACCOMPANIES ALL DEVICES CURRENTLY ADDRESSES POTENTIAL RISKS ASSOCIATED WITH SURGICALLY IMPLANTED MATERIALS. THE INSTRUCTIONS FOR USE STATES IN THE ADVERSE REACTIONS: "COMPLICATIONS ASSOCIATED WITH THE PROPER IMPLANTATION OF THE AVAULTA SOLO SYNTHETIC SUPPORT MAY INCLUDE, BUT ARE NOT LIMITED TO THOSE TYPICALLY ASSOCIATED WITH SURGICALLY IMPLANTABLE MATERIALS, INCLUDING: POSTOPERATIVE HEMATOMA, SEROMA, ABSCESS OR FISTULA FORMATION, OR SCARRING WHICH MAY OCCUR FOLLOWING THE IMPLANT PROCEDURE. URINARY RETENTION, BLADDER OUTLET OBSTRUCTION AND OTHER VOIDING AND DEFECATORY DYSFUNCTIONS. THESE CONDITIONS MAY BE ASSOCIATED WITH OVER-CORRECTION/TOO MUCH TENSION PLACED ON THE IMPLANT. PERORATIONS OR LACERATIONS OF VESSELS, NERVES, BLADDER, BOWEL, URETHRA, RECTUM, OR ANY VISCERA, WHICH MAY OCCUR DURING THE IMPLANTATION PROCEDURE. IRRITATION AT THE OPERATIVE WOUND SITE WHICH MAY ELICIT A FOREIGN BODY RESPONSE THAT LEADS TO WOUND DEHISCENCE, INFLAMMATION AND/OR INFECTION. EXTRUSION THROUGH VAGINAL EPITHELIUM OR EROSION INTO SURROUNDING VISCERA AND/OR MUCOSA. INFLAMMATION, SENSITIZATION, PAIN, DYSPAREUNIA, SCARIFICATION, CONTRACTION, DEVICE MIGRATION AND FAILURE OF THE PROCEDURE RESULTING IN RECURRENCE OF VAGINAL WALL PROLAPSE. URINARY INCONTINENCE (STRESS AND URGE)." (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED IN THE PATIENT'S MEDICAL RECORDS THAT AS A RESULT OF HAVING THE PRODUCT IMPLANTED, THE PATIENT HAS EXPERIENCED HEAVY YELLOWISH DISCHARGE, URINE LEAKAGE, NONHEALING STITCHES, OVERACTIVE BLADDER, PELVIC FLOOR DYSFUNCTION, RECURRENT CYSTOCELE, ATROPHIC VAGINITIS, FAILED TRANSOBTURATOR TAPE PROCEDURE, ANEMIA AND URINARY STRESS INCONTINENCE REQUIRING PELVIC FLOOR PHYSICAL THERAPY, PESSARY PLACEMENT AND VAGINAL SLING PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 AVAULTA BIOSYNTHETIC SUPPORT SYSTEM: POSTERIOR FTL C.R. BARD, INC. (COVINGTON) NA UNK

Patients

Seq Age Sex Outcome Treatment
1 60 YR Female Required Intervention AVAULTA SOLO ANTERIOR SYNTHETIC SUPPORT SYSTEM.| AVAULTA SOLO ANTERIOR SYNTHETIC SUPPORT SYSTEM